メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
Keio University ホーム
ヘルプ&FAQ
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Biogenesis of fibrils requires C-mannosylation of PMEL
Ryota Kawahara
, Tomoko Usami
, Satoko Arakawa
, Hiroki Kamo
, Takehiro Suzuki
, Ryosuke Komatsu
, Hiroyuki Hara
, Yuki Niwa
, Erina Shimizu
, Naoshi Dohmae
, Shigeomi Shimizu
,
Siro Simizu
応用化学科
研究成果
:
Article
›
査読
3
被引用数 (Scopus)
概要
フィンガープリント
フィンガープリント
「Biogenesis of fibrils requires C-mannosylation of PMEL」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Biochemistry, Genetics and Molecular Biology
Amyloid
100%
Biogenesis
100%
Melanosome
100%
Tryptophan
75%
N-Terminus
50%
Wild Type
50%
Consensus Sequence
50%
Secretion (Process)
25%
Mass Spectrometry
25%
Phenylalanine
25%
Western Blot
25%
Maturation
25%
Glycoprotein
25%
Glycosylation
25%
Posttranslational Modification
25%
Immunofluorescence
25%
Transmission Electron Microscopy
25%
Melanocyte
25%
CRISPR/Cas9
25%
Derived Protein
25%
Protein Glycosylation
25%
Keyphrases
Biogenesis
100%
C-mannosylation
100%
Melanosome
42%
N-terminal Fragment
28%
Consensus Sequence
28%
Fibril Formation
28%
Tryptophan Residues
28%
Recombinant
14%
Protein-coding Genes
14%
Western Blot Analysis
14%
Mass Spectrometry Analysis
14%
Phenylalanine
14%
N-glycosylation
14%
Melanocytes
14%
Glycoprotein
14%
Rare Type
14%
Transmission Electron Microscopy
14%
Post-translational Modification
14%
No-report
14%
Tryptophan
14%
Immunofluorescence Analysis
14%
O-glycosylation
14%
Misfolding
14%
Human Melanoma Cells
14%
Melanin Deposition
14%
Melanosome Maturation
14%
Amyloid Fibrils
14%
Protein Glycosylation
14%
SK-MEL-28
14%
SK-MEL-28 Cells
14%
CRISPR-Cas9 Technology
14%
Immunology and Microbiology
Biogenesis
100%
Fibril
100%
Melanosome
80%
Amino Terminal Sequence
40%
Wild Type
40%
Consensus Sequence
40%
Western Blot
20%
Glycosylation
20%
Glycoprotein
20%
Melanoma Cell
20%
Melanocyte
20%
Secretion (Process)
20%
Maturation
20%
Mass Spectrometry
20%
Immunofluorescence
20%
Transmission Electron Microscopy
20%
Protein Processing
20%
Protein Glycosylation
20%
CRISPR/Cas9
20%